Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-03 @ 12:27 AM
Study NCT ID:
NCT00044356
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2002-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Sponsor:
Vical
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Metastatic Melanoma | View |
| None | Malignant Melanoma | View |
| None | Skin Cancer | View |
| None | Tumor | View |
| None | Experimental Treatment | View |
| None | Clinical Trial | View |
| None | Gene Therapy | View |
| None | Gene Delivery | View |
| None | Gene Transfer | View |
| None | Immunotherapy | View |
| None | Cancer | View |
| None | Neoplasm | View |
| None | Lesion | View |
| None | Metastasis | View |
| None | Cancerous mole | View |
| None | Melanoma vaccine | View |
| None | Cancer research | View |
| None | Cancer cells | View |
| None | Allovectin-7® | View |